The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Selling Plan adopted by the reporting person on 3/5/13.
This amendment is to correct the amount of securities beneficially owned in Column 5 of Table 1.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. IRIDEX Corporation next reports earnings on April 28, 2014.
To receive a free e-mail notification whenever IRIDEX Corporation makes a similar move, sign up!